Asia, being the biggest continent in the world presents a variety of opportunities for the clinical trial enterprise. In the past 10 years countries like Korea, Singapore, Taiwan, Hong Kong have distinguished themselves as the more mature markets for companies to conduct both early phase and late-phase studies. Equally active in the Latin America region; Brazil, Argentina and Mexico are the top three clinical trial arenas impacting the global pharmaceutical and biotech industry.
By having a better understanding of the scientific, moral and business drivers that serve as pillars for conducting clinical trials in both Asia and Latin America; companies need to become more operationally sound and better prepared to meet both the challenges and successes of its projects in these emerging and developing regions. It is also incumbent upon the companies that choose to venture into Asia and Latin America to expect that the industry in these regions are primarily and similarly based on building and maintaining relationships to ensure sustainability and building capacity. With these factors in mind, optimising the integration of sponsor-CRO-site functions rests on each stakeholder’s ability to thoroughly recognise each other’s needs and manage each other’s expectations.
Who Should Attend
Programme Leads, Project Leads, Project managers, Heads of Clinical Operations, Client Relations, Site Directors, Study and Project team members
At the conclusion of this tutorial, participants should be able to:
- Identify strategies for building and sustaining Sponsor-CRO-Site partnerships in Asia/Latin America
- Assess the impact of global economics on clinical operations and development
- Apply best practices in choosing the best fitted service provider or functional partner
- Formulate streamlined processes in conjunction with developing a quality oversight plan for identifying risks and tracking issues until resolution